September 24-27 marked the annual American Society for Radiation Oncology (ASTRO) meeting. Radiation oncologists came together in San Diego, California to discuss the latest research and findings related to radiation therapy. Journal of Clinical Pathways has provided some of the most relevant discussions from this meeting.
Almost 50% of patients with cancer who experience severe distress miss at least one radiation therapy appointment and are admitted to the hospital during their treatment.
Consolidative radiation therapy may provide a significant benefit to patients with specific subtypes of diffuse large B-cell lymphoma.
A recent survey found that 90% of patients treated with radiation therapy for breast cancer found their experiences to be less “scary” than anticipated.
Progressive or relapsed Hodgkin lymphoma has demonstrated responsiveness to salvage radiotherapy in pediatric patients.
Many patients with stage IV metastatic cancer achieve stable disease after treatment with radiation therapy and immunotherapy.